Bachem Holding AG (BCHMY)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Anne-Kathrin Stoller Ph.D.
|
Chief Executive Officer | -- | -- | 1974 |
|
Mr. Alain Schaffter
|
Chief Financial Officer | -- | -- | 1977 |
|
Mr. Hans van Hees
|
Chief Operations Officer | -- | -- | 1969 |
|
Mr. Michael Suter
|
Vice President of Global Accounting | -- | -- | -- |
|
Dr. Gunther Loidl
|
Chief Technology Officer | -- | -- | 1970 |
|
Mr. Achim Pluckebaum
|
Chief Information Officer | -- | -- | -- |
|
Ms. Barbora Blaha
|
Head of Investor Relations | -- | -- | -- |
|
Dr. Daniel Grotzky
|
Head of Group Communications | -- | -- | -- |
|
Viviane Minden
|
Chief Human Resources Officer | -- | -- | -- |
|
Mr. Boris Corpataux
|
Chief Commercial Officer, VP & Head Global Strategic Alliances | -- | -- | -- |
Bachem Holding AG
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 2,725
Description
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 20, 2026 at 12:00 AM UTC
Dividend Date
May 5, 2026 at 12:00 AM UTC
Ex-Dividend Date
